Savara (SVRA) Shares Outstanding (2010 - 2026)

Savara's (SVRA) quarterly Shares Outstanding (Entity) came in at $216.4 million in Q2 2025, up 18.54% year-on-year from $182.6 million in Q2 2024, and little changed on a QoQ basis from $216.1 million in Q1 2025.

Savara (SVRA) Shares Outstanding (2010 - 2026) Analysis & Trends

Savara (SVRA) has 12 years of Shares Outstanding (Entity) data on file, last reported at $216.4 million in Q2 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 18.54% year-over-year to $216.4 million in Q2 2025; TTM through Jun 2025 was $216.4 million, a 18.54% increase from a year earlier, with the FY2024 full-year figure at $172.4 million, up 24.81% from the prior year.
  • Shares Outstanding (Entity) for Q2 2025 stood at $216.4 million, roughly flat from $216.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for SVRA reached as high as $216.4 million in Q2 2025 and fell as low as $77.0 million in Q1 2021.
  • Historically, Shares Outstanding (Entity) has averaged $157.1 million across 5 years, with a median of $152.8 million in 2022.
  • Across the five-year window, Shares Outstanding (Entity) surged 188.62% in 2021 and dropped 11.41% in 2023, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $114.0 million in 2021, then jumped by 33.97% to $152.8 million in 2022, then decreased by 9.58% to $138.1 million in 2023, then rose by 24.81% to $172.4 million in 2024, then climbed by 25.52% to $216.4 million in 2025.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $216.4 million in Q2 2025, $216.1 million in Q1 2025, and $172.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Savara 1.24 Bn 1.24 Bn - 253.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 253.28 Mn
Dec 31, 2025 222.39 Mn
Sep 30, 2025 216.46 Mn
Jun 30, 2025 216.43 Mn
Mar 31, 2025 216.15 Mn
Dec 31, 2024 198.19 Mn
Sep 30, 2024 211.85 Mn
Jun 30, 2024 182.58 Mn
Mar 31, 2024 182.55 Mn
Dec 31, 2023 165.20 Mn
Sep 30, 2023 164.34 Mn
Jun 30, 2023 152.80 Mn
Mar 31, 2023 152.78 Mn
Dec 31, 2022 152.77 Mn
Sep 30, 2022 152.77 Mn
Jun 30, 2022 152.77 Mn
Mar 31, 2022 152.77 Mn
Dec 31, 2021 133.92 Mn
Sep 30, 2021 152.59 Mn
Jun 30, 2021 152.46 Mn